Lecture Summary - ASCO 2022 Five-Year Survival Outcomes From CheckMa…

ASCO 2022 Conference Coverage

L. Paz-Ares

ASCO 2022 Five-Year Survival Outcomes From CheckMate 227: Nivo + Ipi…

ASCO 2022 Conference Coverage

L. Paz-Ares

Lecture Summary - ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L …

ASCO 2022 Conference Coverage

F. de Marinis

ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L Pralsetinib in RET…

ASCO 2022 Conference Coverage

F. de Marinis

Lecture Summary - Pralsetinib in Patients (pts) With Advanced or Met…

ASCO 2022 Conference Coverage

L. Wirth

ASCO 2022 Updated Data From the ARROW Trial: Pralsetinib in Patients…

ASCO 2022 Conference Coverage

L. Wirth

Lecture Summary - ASCO 2022 3-Year Update From CheckMate 9LA: 1L Niv…

ASCO 2022 Conference Coverage

L. Paz-Ares

ASCO 2022 3-Year Update From CheckMate 9LA: 1L Nivo + Ipi + 2 Cycles…

ASCO 2022 Conference Coverage

L. Paz-Ares

ASCO 2022 Immunotherapy Nuances in Locally Advanced NSCLC

ASCO 2022 Conference Coverage

J. Varlotto

Lecture Summary - ASCO 2022 Immunotherapy Nuances in Locally Advance…

ASCO 2022 Conference Coverage

J. Varlotto

ASCO 2022 on Acquired EGFR-Resistant Mutations in NSCLC

ASCO 2022 Conference Coverage

L. Raez

Lecture Summary - ASCO 2022 on Acquired EGFR-Resistant Mutations in …

ASCO 2022 Conference Coverage

L. Raez

Lecture Summary - ASCO 2022 on Recurrent SCLC: Can We Change the Par…

ASCO 2022 Conference Coverage

R. Gentzler

Lecture Summary - ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo i…

ASCO 2022 Conference Coverage

B. Chul Cho

ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Ma…

ASCO 2022 Conference Coverage

B. Chul Cho

ASCO 2022 on IO and Chemo-IO for NSCLC With Novel Actionable Oncogen…

ASCO 2022 Conference Coverage

L. Mazzeo, M. Occhipinti

Lecture Summary - ASCO 2022 Impact of Trilaciclib on Multilineage Ch…

ASCO 2022 Conference Coverage

J. Goldschmidt

ASCO 2022 Impact of Trilaciclib on Multilineage Chemo-Induced Myelos…

ASCO 2022 Conference Coverage

J. Goldschmidt

ASCO 2022 Predictors of Biomarker Testing Among Pts With mNSCLC

ASCO 2022 Conference Coverage

N. Robert

ASCO 2022 on a Phase I, Open-Label, Dose Escalation, Confirmation, a…

ASCO 2022 Conference Coverage

J. Heymach

Lecture Summary - ASCO 2022 on a Phase I, Open-Label, Dose Escalatio…

ASCO 2022 Conference Coverage

J. Heymach

Taking on Goliath: Targeting KRAS in NSCLC

Jia Luo

ASCO 2022 on Phase 3 ATLANTIS Trial: Analysis of Patients With Relap…

ASCO 2022 Conference Coverage

A. Navarro

ASCO 2022 on Telisotuzumab Vedotin in Advanced c-Met Overexpressing …

ASCO 2022 Conference Coverage

R. Camidge

Lecture Summary - ASCO 2022 Analysis of Patients With Relapsed SCLC …

ASCO 2022 Conference Coverage

A. Navarro

Lecture Summary - ASCO 2022 on Telisotuzumab Vedotin in Advanced c-M…

ASCO 2022 Conference Coverage

R. Camidge

ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Ad…

ASCO 2022 Conference Coverage

B. Levy

Lecture Summary - ASCO 2022 on ctDNA Shed as a Tool to Select Immune…

ASCO 2022 Conference Coverage

B. Besse

Lecture Summary - ASCO 2022 Combi-TED: A Multicenter Phase II Trial …

ASCO 2022 Conference Coverage

F. Cappuzzo

ASCO 2022 Combi-TED: A Multicenter Phase II Trial Evaluating Efficac…

ASCO 2022 Conference Coverage

F. Cappuzzo

Lecture Summary - ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in…

ASCO 2022 Conference Coverage

K. Gaebe

ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in SCLC and Intracra…

ASCO 2022 Conference Coverage

K. Gaebe

Lecture Summary - ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Stud…

ASCO 2022 Conference Coverage

J. Sands

ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Study of 1L Vibostolim…

ASCO 2022 Conference Coverage

J. Sands

Lecture Summary - ASCO 2022 on Clinical and Genomic Characteristics …

ASCO 2022 Conference Coverage

J. Sands

ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durabl…

ASCO 2022 Conference Coverage

J. Sands

Lecture Summary - ASCO 2022 Three-Year Outcomes and Correlative Anal…

ASCO 2022 Conference Coverage

B. Ricciuti

ASCO 2022 Three-Year Outcomes and Correlative Analyses in Patients W…

ASCO 2022 Conference Coverage

B. Ricciuti

ASCO 2022 on GEOMETRY-N Trial: Neoadjuvant and Adjuvant Capmatinib i…

ASCO 2022 Conference Coverage

J. Lee